The University of Chicago Medicine has begun an $815m project to construct the first standalone cancer care and research pavilion in the US state of Illinois.
This seven-storey, 575,000ft2 facility is designed to advance cancer care and research.
It will house 80 inpatient beds, 90 outpatient exam rooms, imaging and clinical trial spaces, and a range of support services for patients and families.
University of Chicago Health System president Tom Jackiewicz said: “This project represents our latest bold move to make an even bigger difference in cancer care and research.
“This new pavilion will advance scientific discovery so that we can find cures, shape the future of oncology care and treatment, and reduce the cancer burden in the communities that we serve.”
This project aims to address rising cancer rates, particularly on the South Side of Chicago, and improve access to innovative treatments and clinical trials for underrepresented populations.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe pavilion is expected to open in spring 2027 and create over 500 construction jobs with a focus on minority- and women-owned businesses.
UChicago Medicine comprehensive cancer centre director Kunle Odunsi said: “My colleagues and I are determined to make a bigger impact in the field of cancer through the work we do at this new facility.
“We will leverage our location on the University of Chicago campus and our 49-year status as a National Cancer Institute-designated Cancer Center and newest member of the prestigious National Comprehensive Cancer Network to answer cancer’s hardest questions, bring new therapies from discovery to patients, deliver the care our community needs and, ultimately, save lives.”